logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
O

Oncology and Therapy

IF3.2
论文数356
被引数622
期刊论文 356
发表时间
delete
Multimodal Combination Treatment in a Patient-Centered Approach is Associated with Improved Outcome in Relapsed/Refractory Sarcomas in Children: A Comparative Single-Institution Real-World Analysis以患者为中心的多模式联合治疗与儿童复发性/难治性肉瘤的改善结局相关：一项比较性单机构真实世界分析
deleteOncology and Therapy
IF3.2
delete2026-10-20
delete0
deleteOAAI
deleteMichal Kyr; Kristyna Polaskova; Peter Mudry; Vitezslav Dusek; Klara Vejmelkova; Zuzana Kuttnerova; Pavel Tinka; Tomas Merta; Petra Pokorna; Hana Palova; Jakub Neradil; Renata Veselska; Marta Jezova; Ondrej Slaby; Dalibor Valik; Jaroslav Sterba
delete分享
delete收藏
Real-World First-Line Treatment Characteristics and Physician Drivers in Advanced/Metastatic Non–Small Cell Lung Cancer, PD-L1 ≥ 50%, and without Actionable Genomic Alterations真实世界中PD-L1≥50%且无可操作基因组改变晚期/转移性非小细胞肺癌的一线治疗特征及医师驱动因素
deleteOncology and Therapy
IF3.2
delete2026-10-03
delete0
deleteOAAI
deleteDwight H. Owen; Martin Sebastian; Hirotsugu Kenmotsu; Shilpa Viswanathan; Shivani K. Mhatre; Inderjit K. Dhillon; Cosmina Hogea; Siwen Ding; Cameron Forshaw; Hollie Bailey; Delvys Rodríguez-Abreu
delete分享
delete收藏
Neoplasms Metastatic to the Larynx: A Systematic Review喉部转移性肿瘤：一项系统综述
deleteOncology and Therapy
IF3.2
delete2026-09-18
delete0
deleteOAAI
deleteClaudia Montenegro; Fatima-Ezzahra Nassih; Cesare Piazza; Alfio Ferlito
delete分享
delete收藏
Early-Onset Colorectal Cancer: Clinical and Molecular Features with Emerging Insights from Comprehensive Genomic Profiling早发性结直肠癌：临床与分子特征及全基因组分析提供的崭新见解
deleteOncology and Therapy
IF3.2
delete2026-09-16
delete0
deleteOAAI
deleteAmanda Nogueira; Jennifer Brondon; Konstantin Haradinov; Srinivasan Gopalakrishnan; Krane Huang; Debasri Mukherjee; Smita Agarwal; Kyle C. Strickland; Laura Vidal; Chinmayee Joshi; Rebecca Brookes; Rajeev Prasad; Soma Das; Arun K. Mankan; Archana Munje; Begona de las Heras; Brajendra Prasad Singh; Daniel Gandia; Shakti Ramkissoon; Fahmi Sabr Raza; Isagani Chico; Sharadchandra K. Prasad; Judith Perez; Anumeha Prasad; Debashis Sarker; Julien Taieb; Kamal S. Saini
delete分享
delete收藏
Real-World Testing Landscape and Costs of Companion Diagnostics and Comprehensive Genomic Profiling Across Nine Solid Tumors in Japan: A 10-Year Analysis日本九种实体瘤伴随诊断和全面基因组分析的临床测试现状与成本：一项10年分析
deleteOncology and Therapy
IF3.2
delete2026-09-05
delete0
deleteOAAI
deleteKuniko Sunami; Sona-Sanae Aoyagi; Masashi Mikami; Kanae Togo
delete分享
delete收藏
A Qualitative Study of Patient and Caregiver Perspectives on Locally Advanced Head and Neck Cancer in the United States对美国局部晚期头颈癌患者及照护者观点的定性研究
deleteOncology and Therapy
IF3.2
delete2026-09-04
delete0
deleteOAAI
deleteEsther Yu; Veronica Ashton; OluYemisi Falope; Toby Hanna; Teresa Kessell; Matt Scott; Denise D’Andrea; Maureen Tucker O’Malley; Rebecca Genin
delete分享
delete收藏
Patient-Reported Outcome Instruments in Non-Muscle-Invasive Bladder Cancer (NMIBC): A Systematic Review非肌层浸润性膀胱癌（NMIBC）中的患者报告结局测量工具：一项系统评价
deleteOncology and Therapy
IF3.2
delete2026-08-25
delete0
deleteOAAI
deleteIngolf Griebsch; Sunil Shrestha; Carolyn C. Gotay; John L. Gore; Fran Curtis; Andrew Bottomley
delete分享
delete收藏
Exceptional Cure of a Patient with Progressive Advanced Squamous-Cell Lung Cancer after Selenite Treatment followed by Chemotherapy: A Case Report硒酸钠治疗后继以化疗使一例进展期鳞状细胞肺癌患者获得显著缓解：病例报告
deleteOncology and Therapy
IF3.2
delete2026-08-18
delete0
deleteOAAI
deleteOla Brodin; Carlos Fernandez Moro; Mattias Hedman; Ozan Aricak; Tímea Szekerczés; Per Grybäck; Mikael Björnstedt
delete分享
delete收藏
Publisher Correction: Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial出版更正：Ceralasertib联合Durvalumab在中国晚期实体瘤患者中的非随机临床试验
deleteOncology and Therapy
IF3.2
delete2026-08-17
delete0
deleteOAAI
deleteYuping Sun; Jia Zhong; Huiwen Sun; Graeme Parr; Edit Lukacs; Daniel Slade; Yizhao Zhou; Xiaoyu Ren; David Kirk; Aleksandra Kmieciak; Tingting Yao; Jie Wang
delete分享
delete收藏
Ceralasertib Plus Durvalumab in Chinese Patients with Advanced Solid Tumors: A Nonrandomized Clinical Trial塞拉拉塞替联合度伐利尤单抗在中国晚期实体瘤患者中的疗效：一项非随机临床试验
deleteOncology and Therapy
IF3.2
delete2026-07-28
delete0
deleteOAAI
deleteYuping Sun; Jia Zhong; Huiwen Sun; Graeme Parr; Edit Lukacs; Daniel Slade; Yizhao Zhou; Xiaoyu Ren; David Kirk; Aleksandra Kmieciak; Tingting Yao; Jie Wang
delete分享
delete收藏
Clinicians’ Perspectives on the Impact of Different Attributes of Androgen Receptor Pathway Inhibitors on Prostate Cancer Treatment Preferences and Compliance in Mexico临床医生对不同雄激素受体通路抑制剂属性对前列腺癌治疗偏好和依从性的影响的看法（墨西哥）
deleteOncology and Therapy
IF3.2
delete2026-07-23
delete0
deleteOAAI
deleteMario Escobar Gómez; Ana Maria Rodríguez-Leboeuf; Selene Camargo-Correa; Ida Caterina García-Appendini; Arti Dhar; Isabela Rivas; Juan Guillermo Ariza; Pedro A. Madero-Morales
delete分享
delete收藏
A Comprehensive Mapping of Real-World Studies and Data Sources for Oncology in China: Insights into Landscape, Challenges, and Future Direction中国肿瘤学领域真实世界研究和数据来源的全面图谱：对现状、挑战及未来方向的见解
deleteOncology and Therapy
IF3.2
delete2026-07-14
delete0
deleteOAAI
deleteYaqi Jia; Yanbing Li; Siyan Zhan; Jeff Jianfei Guo; Yan-Jun Zhang; Ziheng Guo; Xian Cao
delete分享
delete收藏
IMMPACT-MM: Insights into Multiple Myeloma Patient Outcomes following Early-Line Cilta-cel TreatmentIMMPACT-MM：早期线治疗卡洛利珠单抗后多发性骨髓瘤患者预后的洞察
deleteOncology and Therapy
IF3.2
delete2026-06-28
delete0
deleteOAAI
deleteSridevi Rajeeve; Saurabh P. Nagar; Sabyasachi Ghosh; Victoria Alegria; Justin Hayne; Bruno Emond; Jessica Maitland; Zaina P. Qureshi; Larry D. Anderson
delete分享
delete收藏
Podcast on the Emerging Role of PD-(L)1/VEGF Bispecific Antibodies in the Evolving Advanced Renal Cell Carcinoma Treatment Landscape播客：探讨PD-(L)1/VEGF双特异性抗体在不断发展的高级肾细胞癌治疗格局中的新兴作用
deleteOncology and Therapy
IF3.2
delete2026-06-26
delete0
deleteOAAI
deleteBrian I. Rini; Benjamin Garmezy
delete分享
delete收藏
Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC): An Aggressive Disease Course and Limitations for Personalized Oncology胃肠胰神经内分泌癌(GEP-NEC)：一种侵袭性疾病进程与个性化肿瘤学的局限性
deleteOncology and Therapy
IF3.2
delete2026-06-25
delete0
deleteOAAI
deleteCeline Oanæs; Herish Garresori; Dordi Lea; Marcus T. T. Roalsø; Torjan M. Haslerud; Cato Brede; Kjetil Søreide
delete分享
delete收藏
Real-World Outcomes Among Medicare Beneficiaries Treated with Bruton Tyrosine Kinase Inhibitors for Treatment-Naïve CLL真实世界中接受布鲁顿酪氨酸激酶抑制剂治疗初治CLL的医疗保险受益人结局
deleteOncology and Therapy
IF3.2
delete2026-06-22
delete0
deleteOAAI
deleteDaniel A. Ermann; Deborah M. Stephens; Xiaoliang Wang; Irene Varghese; Heidi De Souza; Caitlin Sheetz; Qianhong Fu; Gregory A. Maglinte; Rhys Williams; Erlene K. Seymour; Derrick van Beuge; Mazyar Shadman; Ryan Jacobs
delete分享
delete收藏
Real-World Actionability Analysis of Comprehensive Genomic Profiling Versus Single/Small-Gene Panels综合基因组分析相较于单/小基因面板的现实世界可操作性分析
deleteOncology and Therapy
IF3.2
delete2026-06-21
delete0
deleteOAAI
deletePaul Spin; Bela Bapat; Chad Moretz; Robert Dumanois; Adrienne M. Gilligan; Mostafa Shokoohi; Emily Borgundvaag; John Fox; Carlo Bifulco; David Bartlett
delete分享
delete收藏
Abemaciclib in HR+, HER2− Breast Cancer: A Narrative Review of the Clinical Evidence阿贝西利在HR+、HER2-乳腺癌中的应用：临床证据的叙述性综述
deleteOncology and Therapy
IF3.2
delete2026-06-15
delete0
deleteOAAI
deleteMiguel Martin; Alexandru Rosca; Alexandra Searles Vitko; Monique Coersmeyer; Katheryn Moreira; Huiping Li; Erica L. Mayer
delete分享
delete收藏
Evaluation of Drug–Drug Interactions Using Drug-PIN® in Patients Receiving Avelumab Maintenance for Advanced Urothelial Carcinoma: Evidence from the MALVA Study (Meet-URO 25)使用Drug-PIN®评估接受阿维鲁唑维持治疗晚期尿路上皮癌患者的药物-药物相互作用：MALVA研究（Meet-URO 25）的证据
deleteOncology and Therapy
IF3.2
delete2026-06-13
delete0
deleteOAAI
deleteGiandomenico Roviello; Mattia Alberto Di Civita; Daniele Santini; Elisabetta Gambale; Lidia Strigari; Simone Scagnoli; Laura Pappalardo; Andrea Torchia; Andrea Botticelli; Serena Pillozzi; Lorenzo Antonuzzo
delete分享
delete收藏
Beyond the BCG Paradox: Biological Rationale and Clinical Evidence for Combining Intravesical BCG with Immune Checkpoint Inhibitors in High-Risk Non-muscle-Invasive Bladder Cancer超越BCG悖论：在高风险非肌层浸润性膀胱癌中联合腔内BCG与免疫检查点抑制剂的生物学理据与临床证据
deleteOncology and Therapy
IF3.2
delete2026-06-11
delete0
deleteOAAI
deleteMichele Musone; Biagio Barone; Stefano Chianese; Paolo Conforti; Antonio Madonna; Silvestro Imperatore; Fabrizio Dinacci; Raffaele Balsamo; Giuseppe Lucarelli; Roberto Falabella; Vincenzo Francesco Caputo; Antonio Luigi Pastore; Andrea Fuschi; Matteo Ferro; Lorenzo Romano; Marco Fabiano; Celeste Manfredi; Gian Maria Busetto; Valerio Santarelli; Francesco Del Giudice; Felice Crocetto
delete分享
delete收藏